CytomX Bounces Back From Trial Setback With Regeneron Bispecific Antibody Partnership

Gets $30m Upfront

 
• By Ayisha Sharma
  
Yellow ball on white background, bounce motion with white powder
CytomX's Share Price Increased By More than 20% In Response To The News • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business